Alcanza Clinical Research

Alcanza is a site network composed of 30 fully owned clinical research sites, some of which are embedded into active practices. Our sites are powered by central teams & operating procedures and integrated through IT systems & cross-functional workstreams. During the acquisition of each site, the network allows each site to maintain their original names given their ongoing relationships created within their respective communities and Sponsor/CRO partnerships.

Alcanza’s Study Delivery team adds a distinct project management component to trials as they are rolled out within our organization. The Study Delivery team is strategically aimed at streamlining study start up processes across all sites, monitor study performance for quality assurance, and provide support to our Sponsor/CRO relationships at the enterprise level. When a new study is awarded to multiple sites in the network, the study is assigned to a therapeutically aligned project manager that acts as a single point of contact for the refinement of working items such as: startup workflows, project updates, operational questions, KPI reports, among other crucial tasks for study startup success.

Alcanza’s patient recruitment strategy integrates site-level assets with a centralized infrastructure to create a process that is highly efficient (for performance) and seamless (for patients). Alcanza sites recruit primarily from their respective robust patient databases that have been compounded for decades, as our sites have been conducting trials for over 30 years. Alcanza sites also benefit from the support of our centralized patient experience team, which drives recruitment efficiency through study advertising, phone recruiting, and funnel management. Further, Alcanza has a deliberate effort to maximize community engagement through participation in community events and partnership with community referral sources.

Given Alcanza’s name, translated from Spanish to English, “Alcanza” means, “Reach”. With this in mind, Alcanza has deliberately created a corporate strategy aimed at engaging historically underrepresented patient populations within clinical trial participation, reflective in our diverse enrollment metrics. To maintain this initiative, the Network has created a specific Diversity, Equity, and Inclusion Committee that promotes and works towards maintaining patient demographic diversification at each site as well as aid with language barriers that may present. At our core, Alcanza’s network composition reflects this effort as our sites are strategically located in areas that have a high concentration of diverse patients. Alcanza actively funds innovative projects across our sites to advance inclusivity, break down hurdles to participation, and thus increase overall engagement.

Alcanza operates under a centralized Quality Management Plan (QMP) that involves proactive quality monitoring and detection systems as well as as-needed support to sites. Our central quality team has 2 leaders overseeing quality control and quality assurance and compliance. On the Medical level, we have a Medical Advisory Board that holds responsibilities with respect to quality as well.

Alcanza operates under a a Medical Advisory Board that brings together experienced physicians and research experts to provide strategic guidance, ensure scientific integrity, and support the safety and quality of our clinical trials.

The Alcanza Network offers 90 beds across 5 site locations for Phase 1/inpatient trials. Alcanza’s network has over 30 years of experience conducting Phase 1 trials across a spectrum of designs, confinement conditions, and populations.

Alcanza’s Business Development function works to build and nurture strategic relationships with our Sponsor & CRO clients that leverages the strengths, integrations, and efficiencies that our network provides. Our team provides a single point of contact to ensure efficient communication throughout the site qualification process as well as a point of escalation for matters that require priority attention.